NIUM, a pioneering startup at the forefront of gut microbiome research and personalized nutrition, is proud to announce the successful closing of its Seed funding round. This critical milestone was achieved with the support of BeAngels as the lead investor, alongside Luxembourg Business Angel Network (LBAN) and a group of private investors.
NIUM’s innovative platform focuses on advancing bioinformatics solutions and in vitro miniaturized fermentation technology. By deepening our understanding of how food impacts the microbiome, NIUM aims to revolutionize the development of healthier nutritional ingredients and personalized health solutions.
The funds raised will be strategically allocated towards accelerating NIUM’s product development, scaling commercialization efforts, and expanding internationally. NIUM’s mission is to revolutionize the intersection of food, biology, and health, ultimately transforming how personalized nutrition and gut health solutions are developed and delivered.
“This funding round marks an important milestone for NIUM as we scale our technology and push the boundaries of microbiome research. We are thrilled to have the support of BeAngels, LBAN, and our private investors as we expand our platform to help companies and researchers develop better nutrition products and advance personalized health.”
Dr. Alberto Noronha, Founder and CEO of NIUM
This successful Seed round marks a critical step in the company’s mission to make personalized nutrition accessible and effective for all, leveraging cutting-edge microbiome science to improve metabolic health and well-being.